Want to see IN:ERIS full AI Analyst Report?

Eris Lifesciences Ltd (ERIS) Financial Statements

0 Followers

Eris Lifesciences Ltd Financial Overview

Eris Lifesciences Ltd's market cap is currently ₹198.82B. The company's EPS TTM is ₹30.53; its P/E ratio is 31.57; and it has a dividend yield of 0.47%. Eris Lifesciences Ltd is scheduled to report earnings on May 20, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 31.29B	₹ 28.79B	₹ 19.91B	₹ 16.62B	₹ 13.26B
Gross Profit	₹ 14.98B	₹ 21.49B	₹ 16.04B	₹ 13.05B	₹ 10.65B
Operating Income	₹ 8.41B	₹ 7.03B	₹ 4.95B	₹ 4.22B	₹ 4.25B
EBITDA	₹ 11.11B	₹ 10.36B	₹ 6.99B	₹ 5.48B	₹ 5.11B
Net Income	₹ 6.20B	₹ 3.52B	₹ 3.92B	₹ 3.82B	₹ 4.06B
Balance Sheet
Cash & Short-Term Investments	₹ 763.80M	₹ 2.28B	₹ 13.39B	₹ 892.43M	₹ 2.12B
Total Assets	₹ 73.66B	₹ 70.33B	₹ 70.49B	₹ 36.67B	₹ 22.72B
Total Debt	₹ 23.59B	₹ 24.78B	₹ 27.81B	₹ 8.77B	₹ 844.07M
Net Debt	₹ 22.91B	₹ 22.55B	₹ 26.87B	₹ 8.21B	₹ 336.13M
Total Liabilities	₹ 34.70B	₹ 37.61B	₹ 38.27B	₹ 14.47B	₹ 3.64B
Stockholders' Equity	₹ 39.03B	₹ 28.54B	₹ 25.86B	₹ 21.96B	₹ 19.08B
Cash Flow
Free Cash Flow	₹ 500.70M	₹ 9.10B	₹ 3.57B	₹ -5.50B	₹ 2.57B
Operating Cash Flow	₹ 3.47B	₹ 10.65B	₹ 4.86B	₹ 2.92B	₹ 3.78B
Investing Cash Flow	₹ -3.72B	₹ -799.70M	₹ -18.55B	₹ -9.82B	₹ -3.20B
Financing Cash Flow	₹ -1.20B	₹ -8.81B	₹ 13.80B	₹ 6.88B	₹ -446.99M

Currency in INR

Eris Lifesciences Ltd Earnings and Revenue History

Income Statement >

Eris Lifesciences Ltd Debt to Assets

Balance Sheet >

Eris Lifesciences Ltd Cash Flow

Cash Flow >

Eris Lifesciences Ltd Forecast EPS vs Actual EPS

Earnings >